The price of sight - Ranibizumab, bevacizumab, and the treatment of macular degeneration

被引:172
作者
Steinbrook, Robert
机构
关键词
D O I
10.1056/NEJMp068185
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1409 / 1412
页数:4
相关论文
共 5 条
[1]   Intravitreal bevacizumab for the management of choroidal neovascularization in age-related macular degeneration [J].
Bashshur, Ziad F. ;
Bazarbachi, Ali ;
Schakal, Alexandre ;
Haddad, Zeina A. ;
El Haibi, Christelle P. ;
Noureddin, Baha' N. .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2006, 142 (01) :1-9
[2]  
MOSHFEGHI AA, IN PRESS OPHTHALMOLO
[3]  
*OPHTH MUT INS CO, 2006, RISK MAN REC OFFL IN
[4]   Intravitreal avastin: The low cost alternative to lucentis? [J].
Rosenfeld, Philip J. .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2006, 142 (01) :141-143
[5]  
ROSENFELD PJ, CURRENT INSIGHTS, V1